At a glance
ClinicalIndex Comparison RecordN/ACompleted· 63 enrolled
Drug / intervention
PureVision2 HD contact lenses +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Study to Evaluate the Product Performance of the PureVision®2 HD Contact Lens
In Brief
A clinical study evaluating PureVision2 HD contact lenses and Spectacles for Myopia. Completed, enrolled 63 participants across 1 site.
Detailed Summary
The objective of this study is to evaluate the product performance of PureVision2 HD contact lenses.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsMyopia
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
201220132014201520162017201820192020202120222023202420252026
Enrollment StartJul 2011
Primary CompletionAug 2011
First PostedAug 2011
Study CompletionSep 2011
TodayJul 2026
First PostedAug 12, 2011
Enrollment StartJul 1, 2011
Primary CompletionAug 1, 2011
Study CompletionSep 1, 2011
TodayJul 2, 2026
Enrollment to primary: 1 monthPosted 14.9 years ago
Interventions
PureVision2 HD contact lensesdevice
Lenses to be worn through 1/2 of an HD movie. Following the movie, all subjects were to wear the dispensed contact lenses on a daily wear basis for approximately one week.
Spectaclesdevice
Spectacles to be worn throughout 1/2 of an HD movie.